References
- Tempescul A, Guillerm G, Douet-Guilbert N, et al. Translocation (10;17)(p15;q21): recurrent anomaly in acute myeloblastic leukemia. Cancer Genet Cytogenet 2007;172:74–76.
- Dicker F, Haferlach C, Kern W, et al. Trisomy 13 is strongly associated with AML1/RUNX1 mutations and increased FLT3 expression in acute myeloid leukemia. Blood 2007;110:1308–1316.
- Pollak C, Hagemeijer A. Abnormalities of the short arm of chromosome 9 with partial loss of material in hematological disorders. Leukemia 1987;1:541–548.
- Barjesteh van Waalwijk van Doorn-Khosrovani S, Erpelinck C, van Putten WL, et al. High EVI1 expression predicts poor survival in acute myeloid leukemia:a study of 319 de novo AML patients. Blood 2003;101:837–845.
- Shah D, Bond M, Kilby AM, et al. Widespread bone disease in acute myeloid leukaemia. Leuk Lymphoma 2001;42:1309–1314.
- Silva ML, Ornellas de Souza MH, Ribeiro RC, et al. Cytogenetic analysis of 100 consecutive newly diagnosed cases of acute lymphoblastic leukemia in Rio de Janeiro. Cancer Genet Cytogenet 2002;137:85–90.
- ISCN (2009). An International System for Human Cytogenetic Nomenclature. Basel: S. Karger; 2009.
- De Braekeleer E, Douet-Guilbert N, Basinko A, et al. Using bacterial artificial chromosomes in leukemia research:the experience at the university cytogenetics laboratory in Brest, France. J Biomed Biotechnol 2011;2011:329471.
- Hateboer G, Gennissen A, Ramos YF, et al. BS69, a novel adenovirus E1A-associated protein that inhibits E1A transactivation. EMBO J 1995;14:3159–3169.
- Masselink H, Bernards R. The adenovirus E1A binding protein BS69 is a corepressor of transcription through recruitment of N-CoR. Oncogene 2000;19:1538–1546.
- Wolford JK, Prochazka M. Structure and expression of the human MTG8/ETO gene. Gene 1998;212:103–109.
- Lutterbach B, Sun D, Schuetz J, et al. The MYND motif is required for repression of basal transcription from the multidrug resistance 1 promoter by the t(8;21) fusion protein. Mol Cell Biol 1998;18:3604–3611.
- Wang J, Hoshino T, Redner RL, et al. ETO, fusion partner in t(8;21) acute myeloid leukemia, represses transcription by interaction with the human N-CoR/mSin3/HDAC1 complex. Proc Natl Acad Sci USA 1998;95:10860–10865.
- Ansieau S, Leutz A. The conserved Mynd domain of BS69 binds cellular and oncoviral proteins through a common PXLXP motif. J Biol Chem 2002;277:4906–4910.
- Ladendorff NE, Wu S, Lipsick JS. BS69, an adenovirus E1A-associated protein, inhibits the transcriptional activity of c-Myb. Oncogene 2001;20:125–132.
- Eryilmaz J, Pan P, Amaya MF, et al. Structural studies of a four-MBT repeat protein MBTD1. PLoS One 2009;4:e7274.
- Boccuni P, MacGrogan D, Scandura JM, et al. The human L(3)MBT polycomb group protein is a transcriptional repressor and interacts physically and functionally with TEL (ETV6). J Biol Chem 2003;278:15412–15420.
- Trojer P, Li G, Sims RJ III, et al. L3MBTL1, a histone-methylation-dependent chromatin lock. Cell 2007;129:915–928.
- Guo Y, Nady N, Qi C, et al. Methylation-state-specific recognition of histones by the MBT repeat protein L3MBTL2. Nucleic Acids Res 2009;37:2204–2210.
- Nady N, Krichevsky L, Zhong N, et al. Histone recognition by human malignant brain tumor domains. J Mol Biol 2012;423:702–718.
- Arai S, Miyazaki T. Impaired maturation of myeloid progenitors in mice lacking novel Polycomb group protein MBT-1. EMBO J 2005;24:1863–1873.
- Gurvich N, Perna F, Farina A, et al. L3MBTL1 polycomb protein, a candidate tumor suppressor in del(20q12) myeloid disorders, is essential for genome stability. Proc Natl Acad Sci USA 2010;107:22552–22557.